Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Neoplasms, Germ Cell and Embryonal 1Medulloblastoma 1Hepatoblastoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Brain Neoplasms 1

Interventions

Ifosfamide 8Doxorubicin 8Blood Specimen Collection 8Radiosurgery 7Proton Therapy 5Surveys and Questionnaires 4Surgical Procedures, Operative 4Standard of Care 4Radiotherapy 4Magnetic Resonance Spectroscopy 4X-Rays 3Vincristine 3Radiation Dose Hypofractionation 3Palliative Care 3Methods 3Mesna 3pegfilgrastim 2pazopanib 2dexamethasone acetate 2Trastuzumab 2Transurethral Resection of Bladder 2Restraint, Physical 2Radiotherapy, Intensity-Modulated 2Protons 2Practice Guidelines as Topic 2Neoadjuvant Therapy 2Methotrexate 2Melphalan 2Heavy Ion Radiotherapy 2Gene Expression Profiling 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Sarcoma × Ursodeoxycholic Acid × Clear all
NCT01505569 2024-02-26

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

Masonic Cancer Center, University of Minnesota

Phase NA Completed
44 enrolled
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Brain Neoplasms, Carcinoma, Renal Cell, Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡